SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-19-017260
Filing Date
2019-11-14
Accepted
2019-11-14 12:25:32
Documents
10
Period of Report
2019-11-13
Effectiveness Date
2019-11-14

Document Format Files

Seq Description Document Type Size
1 def14a.htm DEF 14A 285888
2 image_001.jpg GRAPHIC 2494
3 image_003.jpg GRAPHIC 1007
4 image_004.jpg GRAPHIC 954
5 image_005.jpg GRAPHIC 934
6 image_002.jpg GRAPHIC 6242
7 logo_001.jpg GRAPHIC 7966
8 proxy_001.jpg GRAPHIC 127956
9 proxy_002.jpg GRAPHIC 164992
10 proxy_003.jpg GRAPHIC 171946
  Complete submission text file 0001493152-19-017260.txt   955495
Mailing Address MORRIS CORPORATE CENTER 1, BUILDING C, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER 1, BUILDING C, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054 412-224-6100
INTERPACE BIOSCIENCES, INC. (Filer) CIK: 0001054102 (see all company filings)

IRS No.: 222919486 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24249 | Film No.: 191218223
SIC: 3841 Surgical & Medical Instruments & Apparatus